Stocktoria
INSMED Inc INSM
INSMED Inc financials (annual)
Bars are annual figures from 2016 to 2025; red bars are negative (a loss or cash outflow).
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $606.4M | $363.7M | $305.2M | $245.4M | $188.5M | $164.4M | $136.5M | $9.8M | $0 | $0 |
| Gross profit | — | — | — | — | — | — | $112.3M | $7.4M | $0 | — |
| R&D expense | $771.1M | $598.4M | $571.0M | $397.5M | $272.7M | $181.2M | $131.7M | $145.3M | $109.7M | $122.7M |
| SG&A expense | $701.2M | $461.1M | $344.5M | $265.8M | — | — | — | — | — | — |
| Operating income | -$1.2B | -$878.3M | -$709.6M | -$457.3M | -$375.1M | -$265.2M | -$235.2M | -$307.3M | -$188.9M | -$173.4M |
| Interest expense | $83.8M | $84.9M | $81.7M | $26.4M | $40.5M | $29.6M | $27.7M | $25.5M | $5.9M | $3.5M |
| Income tax | $5.0M | $3.7M | $2.6M | $1.4M | -$1.8M | $1.4M | $777,000 | $201,000 | -$272,000 | $98,000 |
| Net income | -$1.3B | -$913.8M | -$749.6M | -$481.5M | -$434.7M | -$294.1M | -$254.3M | -$324.3M | -$192.6M | -$176.3M |
| EPS (diluted) | $-6.42 | $-5.57 | $-5.34 | $-3.91 | $-3.88 | $-3.01 | $-3.01 | — | — | — |
| Operating cash flow | -$935.0M | -$683.9M | -$536.2M | -$400.4M | -$363.3M | -$219.3M | -$250.6M | -$258.0M | -$159.6M | -$146.7M |
| Free cash flow | -$967.6M | -$705.8M | -$549.5M | -$410.3M | -$370.6M | -$225.6M | -$292.9M | -$271.1M | -$162.6M | -$150.9M |
| Cash & equivalents | $510.4M | $555.0M | $482.4M | $1.1B | $716.8M | $532.8M | $487.4M | $495.1M | $381.2M | $162.6M |
| Inventory | $132.1M | $98.6M | $83.2M | $69.9M | $67.0M | $49.6M | $28.3M | $7.0M | $0 | — |
| Total assets | $2.3B | $2.0B | $1.3B | $1.7B | $1.2B | $796.2M | $742.3M | $604.6M | $462.0M | $238.0M |
| Total liabilities | $1.5B | $1.7B | $1.7B | $1.6B | $833.0M | $520.3M | $480.6M | $396.3M | $101.0M | $83.5M |
| Shareholders' equity | $739.0M | $285.4M | -$331.9M | $88.0M | $410.5M | $275.9M | $261.7M | $208.3M | $361.1M | $154.5M |
Growth · year-over-year
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue growth | +66.7% | +19.2% | +24.4% | +30.2% | +14.6% | +20.5% | +1287.6% | — | — | — |
Each column is the change versus the prior fiscal year. Growth off a negative or zero base is shown as “—”. CAGR is the compound annual revenue growth across the years shown.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.